Eyesight to the Blind-Pharmacotherapy for Retinopathy of Prematurity
Neonatal Netw. 2023 Mar 1;42(2):88-95. doi: 10.1891/NN.2022-0054.ABSTRACTRetinopathy of prematurity (ROP) places preterm infants at significant risk for blindness. Angiogenesis of retinal blood vessels relies on vascular endothelial growth factor (VEGF) released in response to physiologic in utero hypoxia. Relative hyperoxia and disruption in the supply of growth factors after preterm birth lead to cessation of normal vascular growth. Recovery of VEGF production after 32 weeks' postmenstrual age results in aberrant vascular growth, including the formation of fibrous scars with the potential to detach the retina. Ablation o...
Source: Neonatal Network - March 3, 2023 Category: Perinatology & Neonatology Authors: Christopher McPherson Source Type: research
Eyesight to the Blind-Pharmacotherapy for Retinopathy of Prematurity
Neonatal Netw. 2023 Mar 1;42(2):88-95. doi: 10.1891/NN.2022-0054.ABSTRACTRetinopathy of prematurity (ROP) places preterm infants at significant risk for blindness. Angiogenesis of retinal blood vessels relies on vascular endothelial growth factor (VEGF) released in response to physiologic in utero hypoxia. Relative hyperoxia and disruption in the supply of growth factors after preterm birth lead to cessation of normal vascular growth. Recovery of VEGF production after 32 weeks' postmenstrual age results in aberrant vascular growth, including the formation of fibrous scars with the potential to detach the retina. Ablation o...
Source: Neonatal Network - March 3, 2023 Category: Perinatology & Neonatology Authors: Christopher McPherson Source Type: research
Eyesight to the Blind-Pharmacotherapy for Retinopathy of Prematurity
Neonatal Netw. 2023 Mar 1;42(2):88-95. doi: 10.1891/NN.2022-0054.ABSTRACTRetinopathy of prematurity (ROP) places preterm infants at significant risk for blindness. Angiogenesis of retinal blood vessels relies on vascular endothelial growth factor (VEGF) released in response to physiologic in utero hypoxia. Relative hyperoxia and disruption in the supply of growth factors after preterm birth lead to cessation of normal vascular growth. Recovery of VEGF production after 32 weeks' postmenstrual age results in aberrant vascular growth, including the formation of fibrous scars with the potential to detach the retina. Ablation o...
Source: Neonatal Network - March 3, 2023 Category: Perinatology & Neonatology Authors: Christopher McPherson Source Type: research
Eyesight to the Blind-Pharmacotherapy for Retinopathy of Prematurity
Neonatal Netw. 2023 Mar 1;42(2):88-95. doi: 10.1891/NN.2022-0054.ABSTRACTRetinopathy of prematurity (ROP) places preterm infants at significant risk for blindness. Angiogenesis of retinal blood vessels relies on vascular endothelial growth factor (VEGF) released in response to physiologic in utero hypoxia. Relative hyperoxia and disruption in the supply of growth factors after preterm birth lead to cessation of normal vascular growth. Recovery of VEGF production after 32 weeks' postmenstrual age results in aberrant vascular growth, including the formation of fibrous scars with the potential to detach the retina. Ablation o...
Source: Neonatal Network - March 3, 2023 Category: Perinatology & Neonatology Authors: Christopher McPherson Source Type: research
Eyesight to the Blind-Pharmacotherapy for Retinopathy of Prematurity
Neonatal Netw. 2023 Mar 1;42(2):88-95. doi: 10.1891/NN.2022-0054.ABSTRACTRetinopathy of prematurity (ROP) places preterm infants at significant risk for blindness. Angiogenesis of retinal blood vessels relies on vascular endothelial growth factor (VEGF) released in response to physiologic in utero hypoxia. Relative hyperoxia and disruption in the supply of growth factors after preterm birth lead to cessation of normal vascular growth. Recovery of VEGF production after 32 weeks' postmenstrual age results in aberrant vascular growth, including the formation of fibrous scars with the potential to detach the retina. Ablation o...
Source: Neonatal Network - March 3, 2023 Category: Perinatology & Neonatology Authors: Christopher McPherson Source Type: research
Eyesight to the Blind-Pharmacotherapy for Retinopathy of Prematurity
Neonatal Netw. 2023 Mar 1;42(2):88-95. doi: 10.1891/NN.2022-0054.ABSTRACTRetinopathy of prematurity (ROP) places preterm infants at significant risk for blindness. Angiogenesis of retinal blood vessels relies on vascular endothelial growth factor (VEGF) released in response to physiologic in utero hypoxia. Relative hyperoxia and disruption in the supply of growth factors after preterm birth lead to cessation of normal vascular growth. Recovery of VEGF production after 32 weeks' postmenstrual age results in aberrant vascular growth, including the formation of fibrous scars with the potential to detach the retina. Ablation o...
Source: Neonatal Network - March 3, 2023 Category: Perinatology & Neonatology Authors: Christopher McPherson Source Type: research
Eyesight to the Blind-Pharmacotherapy for Retinopathy of Prematurity
Neonatal Netw. 2023 Mar 1;42(2):88-95. doi: 10.1891/NN.2022-0054.ABSTRACTRetinopathy of prematurity (ROP) places preterm infants at significant risk for blindness. Angiogenesis of retinal blood vessels relies on vascular endothelial growth factor (VEGF) released in response to physiologic in utero hypoxia. Relative hyperoxia and disruption in the supply of growth factors after preterm birth lead to cessation of normal vascular growth. Recovery of VEGF production after 32 weeks' postmenstrual age results in aberrant vascular growth, including the formation of fibrous scars with the potential to detach the retina. Ablation o...
Source: Neonatal Network - March 3, 2023 Category: Perinatology & Neonatology Authors: Christopher McPherson Source Type: research
Eyesight to the Blind-Pharmacotherapy for Retinopathy of Prematurity
Neonatal Netw. 2023 Mar 1;42(2):88-95. doi: 10.1891/NN.2022-0054.ABSTRACTRetinopathy of prematurity (ROP) places preterm infants at significant risk for blindness. Angiogenesis of retinal blood vessels relies on vascular endothelial growth factor (VEGF) released in response to physiologic in utero hypoxia. Relative hyperoxia and disruption in the supply of growth factors after preterm birth lead to cessation of normal vascular growth. Recovery of VEGF production after 32 weeks' postmenstrual age results in aberrant vascular growth, including the formation of fibrous scars with the potential to detach the retina. Ablation o...
Source: Neonatal Network - March 3, 2023 Category: Perinatology & Neonatology Authors: Christopher McPherson Source Type: research
Eyesight to the Blind-Pharmacotherapy for Retinopathy of Prematurity
Neonatal Netw. 2023 Mar 1;42(2):88-95. doi: 10.1891/NN.2022-0054.ABSTRACTRetinopathy of prematurity (ROP) places preterm infants at significant risk for blindness. Angiogenesis of retinal blood vessels relies on vascular endothelial growth factor (VEGF) released in response to physiologic in utero hypoxia. Relative hyperoxia and disruption in the supply of growth factors after preterm birth lead to cessation of normal vascular growth. Recovery of VEGF production after 32 weeks' postmenstrual age results in aberrant vascular growth, including the formation of fibrous scars with the potential to detach the retina. Ablation o...
Source: Neonatal Network - March 3, 2023 Category: Perinatology & Neonatology Authors: Christopher McPherson Source Type: research
Eyesight to the Blind-Pharmacotherapy for Retinopathy of Prematurity
Neonatal Netw. 2023 Mar 1;42(2):88-95. doi: 10.1891/NN.2022-0054.ABSTRACTRetinopathy of prematurity (ROP) places preterm infants at significant risk for blindness. Angiogenesis of retinal blood vessels relies on vascular endothelial growth factor (VEGF) released in response to physiologic in utero hypoxia. Relative hyperoxia and disruption in the supply of growth factors after preterm birth lead to cessation of normal vascular growth. Recovery of VEGF production after 32 weeks' postmenstrual age results in aberrant vascular growth, including the formation of fibrous scars with the potential to detach the retina. Ablation o...
Source: Neonatal Network - March 3, 2023 Category: Perinatology & Neonatology Authors: Christopher McPherson Source Type: research
Eyesight to the Blind-Pharmacotherapy for Retinopathy of Prematurity
Neonatal Netw. 2023 Mar 1;42(2):88-95. doi: 10.1891/NN.2022-0054.ABSTRACTRetinopathy of prematurity (ROP) places preterm infants at significant risk for blindness. Angiogenesis of retinal blood vessels relies on vascular endothelial growth factor (VEGF) released in response to physiologic in utero hypoxia. Relative hyperoxia and disruption in the supply of growth factors after preterm birth lead to cessation of normal vascular growth. Recovery of VEGF production after 32 weeks' postmenstrual age results in aberrant vascular growth, including the formation of fibrous scars with the potential to detach the retina. Ablation o...
Source: Neonatal Network - March 3, 2023 Category: Perinatology & Neonatology Authors: Christopher McPherson Source Type: research
Eyesight to the Blind-Pharmacotherapy for Retinopathy of Prematurity
Neonatal Netw. 2023 Mar 1;42(2):88-95. doi: 10.1891/NN.2022-0054.ABSTRACTRetinopathy of prematurity (ROP) places preterm infants at significant risk for blindness. Angiogenesis of retinal blood vessels relies on vascular endothelial growth factor (VEGF) released in response to physiologic in utero hypoxia. Relative hyperoxia and disruption in the supply of growth factors after preterm birth lead to cessation of normal vascular growth. Recovery of VEGF production after 32 weeks' postmenstrual age results in aberrant vascular growth, including the formation of fibrous scars with the potential to detach the retina. Ablation o...
Source: Neonatal Network - March 3, 2023 Category: Perinatology & Neonatology Authors: Christopher McPherson Source Type: research
Eyesight to the Blind-Pharmacotherapy for Retinopathy of Prematurity
Neonatal Netw. 2023 Mar 1;42(2):88-95. doi: 10.1891/NN.2022-0054.ABSTRACTRetinopathy of prematurity (ROP) places preterm infants at significant risk for blindness. Angiogenesis of retinal blood vessels relies on vascular endothelial growth factor (VEGF) released in response to physiologic in utero hypoxia. Relative hyperoxia and disruption in the supply of growth factors after preterm birth lead to cessation of normal vascular growth. Recovery of VEGF production after 32 weeks' postmenstrual age results in aberrant vascular growth, including the formation of fibrous scars with the potential to detach the retina. Ablation o...
Source: Neonatal Network - March 3, 2023 Category: Perinatology & Neonatology Authors: Christopher McPherson Source Type: research
Eyesight to the Blind-Pharmacotherapy for Retinopathy of Prematurity
Neonatal Netw. 2023 Mar 1;42(2):88-95. doi: 10.1891/NN.2022-0054.ABSTRACTRetinopathy of prematurity (ROP) places preterm infants at significant risk for blindness. Angiogenesis of retinal blood vessels relies on vascular endothelial growth factor (VEGF) released in response to physiologic in utero hypoxia. Relative hyperoxia and disruption in the supply of growth factors after preterm birth lead to cessation of normal vascular growth. Recovery of VEGF production after 32 weeks' postmenstrual age results in aberrant vascular growth, including the formation of fibrous scars with the potential to detach the retina. Ablation o...
Source: Neonatal Network - March 3, 2023 Category: Perinatology & Neonatology Authors: Christopher McPherson Source Type: research
Eyesight to the Blind-Pharmacotherapy for Retinopathy of Prematurity
Neonatal Netw. 2023 Mar 1;42(2):88-95. doi: 10.1891/NN.2022-0054.ABSTRACTRetinopathy of prematurity (ROP) places preterm infants at significant risk for blindness. Angiogenesis of retinal blood vessels relies on vascular endothelial growth factor (VEGF) released in response to physiologic in utero hypoxia. Relative hyperoxia and disruption in the supply of growth factors after preterm birth lead to cessation of normal vascular growth. Recovery of VEGF production after 32 weeks' postmenstrual age results in aberrant vascular growth, including the formation of fibrous scars with the potential to detach the retina. Ablation o...
Source: Neonatal Network - March 3, 2023 Category: Perinatology & Neonatology Authors: Christopher McPherson Source Type: research
